RxDoctor Payments Data

David Coons, DO

Sports Medicine · Tacoma, WANPI 1215956024

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (37.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Arthrex at 43.5% of the total.

$9,138in general payments, 2019–2025

Across 75 payments — averaging $121.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Summit Surgical Corp.$4K
  • Invictus Surgical Incorporated$617
  • Zimmer Biomet$257
  • Smith+Nephew$237
  • Innovation Technologies Inc$127
  • plus $141 from 2 others

What the payments were for

  • Travel & lodging$3,27736%
  • Food & beverage$3,46138%
  • Education$2,40026%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex47$3,978
Summit Surgical Corp.8$3,782
Invictus Surgical Incorporated5$617
Zimmer Biomet6$257
Smith+Nephew6$237
Innovation Technologies Inc1$127
Vericel Corporation1$124
GE HealthCare1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,138 in reported general payments places this provider in the 85th percentile of 132 sports medicine providers in Washington.

See all sports medicine providers in Washington

Medicare billing

Part B allowed, 2024
$266,100
Medicare patients
469
Services billed
4,796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam24$63

Paid to pharmacies, not to this prescriber.

Other sports medicine in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →